Roche’s Half-Year Results 2022
Agenda
Overview
Pharmaceuticals Division
Diagnostics Division
Financial Results
Questions and answers
Severin Schwan, CEO Roche Group
Bill Anderson, CEO Roche Pharmaceuticals
Thomas Schinecker, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer

Webinar Replay

Please register here to access the replay*

*Privacy notice

Investors
Past IR Events
View more Events

Roche has published it's Half-Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 21 July 2022.

Downloads

Discover more